HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BMS buys out Axion's 50% of JV Oncology Therapeutics

Executive Summary

Bristol Myers Squibb will buy out Axion's (cancer pharmaceutical services) 50% share of the two companies' joint venture Oncology Therapeutic Network for $86mm in newly-issued BMS stock.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Partial Acquisition

Related Companies